Actions du secteur de la santé
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2901 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.95 USD | -2.64% | -13.74% | +1.37% | +52.06% | 510.77 M USD | ||
| 2904 | EVH Evolent Health, Inc Class A Common Stock | 4.50 USD | -2.39% | -3.43% | +43.31% | -53.08% | 508.77 M USD | ||
| 2910 | NPCE Neuropace, Inc. - Common Stock | 14.65 USD | +1.67% | +4.27% | +12.26% | +38.47% | 502.85 M USD | ||
| 2912 | SRTA Strata Critical Medical, Inc. - Class A Common Stock | 5.66 USD | -5.19% | -5.67% | +12.08% | +31.02% | 500.72 M USD | ||
| 2926 | SENS Senseonics Holdings, Inc. - Common Stock | 9.23 USD | -1.07% | -1.39% | +82.05% | +17.13% | 488.03 M USD | ||
| 2935 | PRTA Prothena Corporation plc - Ordinary Shares | 9.35 USD | +0.21% | -1.68% | +14.44% | +14.44% | 480.00 M USD | ||
| 2942 | KMDA Kamada Ltd. - Ordinary Shares | 8.23 USD | -0.72% | -2.49% | +16.08% | +17.40% | 474.76 M USD | ||
| 2946 | PBYI Puma Biotechnology Inc - Common Stock | 9.11 USD | +0.55% | -1.19% | +14.16% | +80.40% | 470.26 M USD | ||
| 2947 | EDIT Editas Medicine, Inc. - Common Stock | 3.06 USD | -3.16% | -0.33% | +18.60% | +21.43% | 469.95 M USD | ||
| 2949 | SGHT Sight Sciences, Inc. - Common Stock | 8.50 USD | -0.58% | +1.55% | +58.88% | +114.65% | 468.25 M USD | ||
| 2953 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.36 USD | +0.69% | -5.83% | -17.11% | +285.84% | 465.08 M USD | ||
| 2958 | NRC National Research Corporation | 20.94 USD | -4.16% | -4.82% | +7.44% | +43.92% | 463.18 M USD | ||
| 2960 | CLPT ClearPoint Neuro Inc. - Common Stock | 15.14 USD | -2.64% | -1.56% | +1.54% | +47.13% | 461.83 M USD | ||
| 2962 | EVMN Evommune, Inc. Common Stock | 12.66 USD | -4.24% | -9.57% | +13.64% | -26.91% | 459.46 M USD | ||
| 2966 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.71 USD | -3.64% | -9.73% | +6.30% | +44.36% | 456.42 M USD | ||
| 2975 | RZLT Rezolute, Inc. - Common Stock | 4.69 USD | +1.52% | -5.06% | +3.30% | -34.13% | 451.61 M USD | ||
| 2977 | OCGN Ocugen, Inc. - Common Stock | 1.33 USD | +0.76% | -4.32% | +7.26% | +31.68% | 451.02 M USD | ||
| 2980 | AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | 0.00% | -1.72% | +4.28% | -10.41% | 449.98 M USD | ||
| 2984 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.60 USD | +2.38% | -14.76% | +20.43% | +366.67% | 446.90 M USD | ||
| 2986 | CARL Carlsmed, Inc. - Common Stock | 16.29 USD | -3.50% | +3.23% | +26.08% | +22.57% | 444.76 M USD |
Nouvelles Actions du secteur de la santé
BMO relève son objectif de cours sur Protagonist Therapeutics après l’approbation de Mimrylo
Piper Sandler anticipe une surperformance du secteur biotech jusqu’en 2026
Piper Sandler relève l’objectif de cours de BioMarin après un accord sur les brevets
RBC Capital maintient sa note sur Regeneron grâce aux perspectives de collaboration
L’action Pulse Biosciences atteint un record historique à 51,0 USD
L’action Organon & Co atteint un sommet annuel à 13,78$
L’action Royalty Pharma atteint un sommet historique à 62,48 USD
Gainers Actions du secteur de la santé
VBIO Valion Bio, Inc. - Common stock | 3.57 | +2875.00% |
NXL Nexalin Technology, Inc. - Common Stock | 7.23 | +2792.00% |
GCTK GlucoTrack, Inc. - Common Stock | 4.25 | +1417.86% |
ARTL Artelo Biosciences, Inc. - Common Stock | 6.36 | +863.64% |
CALC CalciMedica, Inc. - Common Stock | 2.14 | +365.22% |
CINGW Cingulate Inc. - Warrants | 0.0088 | +41.94% |
RDHL Redhill Biopharma Ltd - American Depositary Shares | 0.90 | +36.36% |
LIMNW Liminatus Pharma, Inc. - Warrants | 0.0552 | +26.90% |
Losers Actions du secteur de la santé
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0004 | -42.86% |
TNONW Tenon Medical, Inc. - Warrant | 0.0074 | -24.49% |
YDES YD Bio Limited - Ordinary Shares | 3.71 | -22.71% |
PIIIW P3 Health Partners Inc. - Warrant | 0.0101 | -21.71% |
CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 6.69 | -20.92% |
BGM BGM Group Ltd. - Class A Ordinary Shares | 0.27 | -18.18% |
SCLXW Scilex Holding Company - Warrant | 0.1300 | -17.67% |
AEMD Aethlon Medical, Inc. - Common Stock | 2.06 | -17.27% |